期刊
PLASTIC AND RECONSTRUCTIVE SURGERY-GLOBAL OPEN
卷 7, 期 4, 页码 -出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/GOX.0000000000002185
关键词
-
类别
资金
- American Association of Plastic Surgeons/Plastic Surgery Foundation (AAPS/PSF) Academic Scholar Award
- Association for Academic Surgery's Joel J. Roslyn Award
Venous thromboembolism is an important patient safety in plastic surgery, and multiple clinical trials in the past 10 years have provided increased understanding of the risks and benefits of venous thromboembolism prevention strategies. This paper provides an exhaustive discussion of the rationale behind and methodology for an in progress randomized double-blind clinical trial in plastic surgery inpatients, in which the 2 study arms are enoxaparin 40mg twice daily and enoxaparin 0.5mg/kg twice daily. The trial's primary aims are to: (1) demonstrate whether enoxaparin 0.5mg/kg twice daily is superior to enoxaparin 40mg twice daily for the pharmacokinetic endpoint of overanticoagulation (anti-Factor Xa > 0.4 IU/mL) and (2) demonstrate whether enoxaparin 0.5mg/kg twice daily is not inferior to enoxaparin 40mg twice daily for the pharmacokinetic endpoint of underanticoagulation (anti-Factor Xa < 0.2 IU/mL). The results of this trial will provide Level I evidence to help guide plastic surgeon's choice of postoperative prophylactic anticoagulation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据